Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel

ClinicalTrials.gov ID: NCT05776134

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05776134. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:47 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this study is to provide access to brexucabtagene autoleucel for patients diagnosed with a disease approved for treatment with brexucabtagene autoleucel, that is otherwise out of specification for commercial release.

Study identification

NCT ID: NCT05776134
Recruitment status: Available
Study type: Expanded access
Phase: Not listed
Lead sponsor: Kite, A Gilead Company; Industry
Enrollment: Not listed

Conditions and interventions

Conditions

Interventions

Brexucabtagene Autoleucel Biological

Biological

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Not listed
Primary completion: Not listed
Completion: Not listed
Last update posted: Nov 2, 2026

United States locations

U.S. sites: 50
U.S. states: 31
U.S. cities: 42

Facility	City	State	ZIP	Site status
University of Alabama at Birmingham	Birmingham	Alabama	35234	Available
Banner MD Anderson Cancer Center	Gilbert	Arizona	85234	Available
The University of Arizona Cancer Center	Tucson	Arizona	85724	Available
City of Hope	Duarte	California	91010	Available
Colorado Blood Cancer Institute	Denver	Colorado	80218	Available
Mayo Clinic Jacksonville	Jacksonville	Florida	32224	Available
Orlando Health Cancer Institute	Orlando	Florida	32806	Available
Moffitt Cancer Center	Tampa	Florida	33612	Available
Winship Cancer Institute	Atlanta	Georgia	30322	Available
Northside Hospital	Atlanta	Georgia	30342	Available
St. Luke's Cancer Institute	Boise	Idaho	83712	Available
Northwestern Memorial Hospital	Chicago	Illinois	60611	Available
The University of Kansas Medical Center	Westwood	Kansas	66205	Available
University of Maryland Cancer Center	Baltimore	Maryland	21201	Available
Massachusetts General Hospital	Boston	Massachusetts	02114	Available
Beth Israel Deaconess Medical Center	Boston	Massachusetts	02215	Available
Dana Farber Cancer Institute - Chestnut Hill	Boston	Massachusetts	02215	Available
University of Michigan	Ann Arbor	Michigan	48109	Available
Mayo Clinic	Rochester	Minnesota	55902	Available
Washington University School of Medicine- Siteman Cancer Center	St Louis	Missouri	63110	Available
University of Nebraska Medical Center	Omaha	Nebraska	68198	Available
John Theurer Cancer Center at Hackensack University Medical Center	Hackensack	New Jersey	07601	Available
Roswell Park Cancer Institute	Buffalo	New York	14263	Available
Weill Cornell Medicine - NewYork-Presbyterian Hospital	New York	New York	10021	Available
Icahn School of Medicine at Mount Sinai	New York	New York	10029	Available
University of Rochester Medical Center	Rochester	New York	14642	Available
Montefiore Medical Center (MMC)	The Bronx	New York	10467	Available
UNC Hospitals, The University of North Carolina at Chapel Hill	Chapel Hill	North Carolina	27514	Available
Sanford Roger Maris Cancer Center	Fargo	North Dakota	58102	Available
Cleveland Clinic	Cleveland	Ohio	44195	Available
The Ohio State University	Columbus	Ohio	43201	Available
OH Health Stephenson Cancer Center	Oklahoma City	Oklahoma	73104	Available
Oregon Health & Science University	Portland	Oregon	97239	Available
Hospital of the University of Pennsylvania	Philadelphia	Pennsylvania	19104	Available
Fox Chase Cancer Center	Philadelphia	Pennsylvania	19111	Available
UPMC Hillman Cancer Center	Pittsburgh	Pennsylvania	15232	Available
Avera Cancer Institute	Sioux Falls	South Dakota	57105	Available
Sarah Canon Research Institute	Nashville	Tennessee	37203	Available
Tennessee Oncology	Nashville	Tennessee	37203	Available
Vanderbilt-Ingrim Cancer Center	Nashville	Tennessee	37232	Available
Baylor University Medical Center	Dallas	Texas	75246	Available
Houston Methodist Hospital	Houston	Texas	77030	Available
MD Anderson Cancer Center	Houston	Texas	77030	Available
Methodist Healthcare System of San Antonio dba Methodist Hospital	San Antonio	Texas	782229	Available
Huntsman Cancer Institute, University of Utah	Salt Lake City	Utah	84112	Available
University of Virginia Comprehensive Cancer Center	Charlottesville	Virginia	22903	Available
Virginia Commonwealth University	Richmond	Virginia	23298	Available
Fred Hutchinson Cancer Center	Seattle	Washington	98109	Available
West Virginia University	Morgantown	West Virginia	26506	Available
Medical College of Wisconsin	Milwaukee	Wisconsin	53227	Available

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05776134, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Nov 2, 2026 · Synced Nov 15, 2026